Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutical Biology is Scopus-indexed (Q1, CiteScore 12.4), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1388-0209Verify ISSN ↗1744-5116Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 3 / 115 | 97th | Q1 |
| Pharmaceutical Science | 14 / 191 | 92nd | Q1 |
| Drug Discovery | 12 / 161 | 92nd | Q1 |
| Pharmacology | 25 / 328 | 92nd | Q1 |
| Molecular Medicine | 19 / 179 | 89th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1975–present (also 1961–1972), best quartile Q1, CiteScore 12.4.
Pharmaceutical Biology is Q1 in Complementary and Alternative Medicine (rank 3 of 115), Q1 in Pharmaceutical Science (rank 14 of 191) and Q1 in Drug Discovery (rank 12 of 161), by CiteScore 2025. It is ranked in 5 subject areas in all.
Pharmaceutical Biology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.4, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.121, quartile Q1, with an H-index of 103.
The publisher lists an article processing charge of about US$2,557 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmaceutical Biology is published by Taylor and Francis Ltd. Its print ISSN is 1388-0209 and its online ISSN is 1744-5116.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Pharmaceutical Biology has an h-index of 115 and a 2-year mean of 6.6 citations per paper (OpenAlex). Its Scopus CiteScore is 12.4, quartile Q1. On 2-year citations it ranks #5 of 109 Scopus journals in Complementary and Alternative Medicine.
Pharmaceutical Biology published 63 papers in 2025; its busiest recent year was 2022 with 218. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (43.2%), United States (11.1%) and Thailand (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 12 retracted papers are recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.